SEC sues California biotech company for misleading investors about COVID-19 tests
The U.S. Securities and Exchange Commission sued Decision Diagnostics Corp and its chief executive for allegedly misleading investors by promising the biotechnology company could test for COVID-19 with a finger-prick of blood and provide accurate results in less than one minute.